[Limit on therapy of patients with collagen disease (discussion)].
Tomioka
H
H
Shiozawa
S
S
Takabayashi
K
K
Hashimoto
H
H
Yamamoto
K
K
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000032:analysis; D017152:Antibodies, Antiphospholipid / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D003095:Collagen Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D016207:Cytokines / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D015415:Biomarkers; D016207:Cytokines; D007166:Immunosuppressive Agents; D013256:Steroids